|
Key Drug Pipeline Databases on Dialog
Lesson 3:
Pharmaprojects
(File 128/928)
Objectives
About Pharmaprojects
Why Pharmaprojects?
The Record
Exercises
Summary
Glossary
Print Tips
About the Icons
Links to Other Lessons:
Technical Help
with Online Courses
Need Help?
E-mail the
|
|
|
|
Lesson 3: Pharmaprojects (File 128/928)
About Pharmaprojects...
Because it is an authoritative source and covers 40 countries, I think Pharmaprojects will be able to provide me with the additional licensing information that Sharon wants. I'll take a look at the file in detail.
Pharmaprojects is compiled from both published and unpublished sources.
Published sources include
press releases, annual reports, PuBMed abstracts,
analysts meetings and conference abstracts.
A considerable amount of information is obtained directly from the companies involved in product development.
In addition, Pharmaprojects staff attend
international meetings to obtain information directly
from research scientists. They also scan conference
proceedings and the scientific and medical literature
to track new products.
Additional key points about this file are:
- Contains extensive company information—originating company and development status, licensees and development status, and patent/priority data.
- Information provided in the form of 73 searchable
fields including: drug name, synonyms, chemical
name, chemical structure, CAS® Registry Number,
rigorously classified therapeutic activity, molecular
formula, and pharmacology data. Also present are
indications, route of administration, and origin
of material, as well as recently added fields for
pharmacokinetics, drug protein target, Lipinsky “Rule
of 5” data and latest update. Target family
fields (e.g GPCR or kinase), NCE classifications
and ability to search for future or current licensing
opportunities were added in 2006 and 2007.
- Identifies if a substance is a new chemical entity.
- New Target Data contains links to the Entrez
Gene database from the U.S. National Center for
Biotechnology Information (NCBI). In many records
the link connects to an entry in the database for
the gene whose product is targeted by the drug
of record. New Pharmaprojects fields include searchable
Target Data Codes (TG=, /TG) and Target Families
( /TF).
- Pharmaprojects offers indexing on major events
in the drug’s development and provides a
latest update field, which makes Pharmaprojects
an excellent database to create Alerts to monitor
progress
- File 128 is the public file; File 928 is the
subscriber file, available to those who subscribe
to the web Pharmaprojects.
- Covers 1980 to the present, for products in active development
and those
that have ceased development or launched in all their
major markets.
- Contains stage of development in up to 40 countries
- A linking (/lg) field shows the relationship between
therapeutic indication, pharmacological activity
and development status.
- Status and Indications fields allow the searcher
to combine country and status and indications and
status
Go to the next page.
3-2
|